Sherif A Ibrahim
Overview
Explore the profile of Sherif A Ibrahim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
376
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Y, He W, Ibrahim S, He Q, Jin J
Oxid Med Cell Longev
. 2021 Jul;
2021:6634601.
PMID: 34257814
Oxidative stress (OxS) is a wildly described cause of damage to macromolecules, resulting in abnormal physiological conditions. In recent years, a few studies have shown that oxidation/antioxidation imbalance plays a...
2.
Kanada M, Kim B, Hardy J, Ronald J, Bachmann M, Bernard M, et al.
Mol Cancer Ther
. 2019 Aug;
18(12):2331-2342.
PMID: 31451563
An emerging approach for cancer treatment employs the use of extracellular vesicles, specifically exosomes and microvesicles, as delivery vehicles. We previously demonstrated that microvesicles can functionally deliver plasmid DNA to...
3.
Mohamed H, Gadalla R, El-Husseiny N, Hassan H, Wang Z, Ibrahim S, et al.
J Adv Res
. 2019 Mar;
16:75-86.
PMID: 30899591
The aim of the present study was to evaluate the expression levels of the aryl hydrocarbon receptor (AHR) and its target gene and to correlate their expression with Wnt5a/b-β-catenin, the...
4.
Taher F, Ibrahim S, Abd El-Aziz A, Abou El-Nour M, El-Sheikh M, El-Husseiny N, et al.
Int J Biol Macromol
. 2018 Dec;
126:478-487.
PMID: 30572045
Actually, the most common cancer in women is the breast cancer which is the second most widespread cancer overall. In 2018, there were over two million new cases of women...
5.
Ibrahim S, El-Ghonaimy E, Hassan H, Mahana N, Mahmoud M, El-Mamlouk T, et al.
J Adv Res
. 2016 Aug;
7(5):661-70.
PMID: 27482469
Hormonal-receptor positive (HRP) breast cancer patients with positive metastatic axillary lymph nodes are characterized by poor prognosis and increased mortality rate. The mechanisms by which cancer cells invade lymph nodes...
6.
El-Ghonaimy E, Ibrahim S, Youns A, Hussein Z, Nouh M, El-Mamlouk T, et al.
Tumour Biol
. 2016 Jul;
37(10):14333.
PMID: 27473080
No abstract available.
7.
Elghonaimy E, Ibrahim S, Youns A, Hussein Z, Nouh M, El-Mamlouk T, et al.
Tumour Biol
. 2016 Jun;
37(9):12441-12453.
PMID: 27329104
Epithelial-mesenchymal transition (EMT) is an essential process in breast cancer metastasis. The aim of the present study was to determine the role of secretions of tumor-associated leukocytes (TALs) isolated from...
8.
El-Ghonaimy E, El-Shinawi M, Ibrahim S, El-Ghazaly H, Abd-El-Tawab R, Nouh M, et al.
FEBS J
. 2014 Oct;
282(2):271-82.
PMID: 25327843
Tumor metastasis to lymph nodes is most deadly complication among breast cancer patients. Herein, we investigated the molecular mechanism by which tumor-associated leukocytes (TALs) mediate lymph node metastasis. The density...
9.
Ibrahim S, Hassan H, Gotte M
FEBS J
. 2014 Aug;
281(22):5009-22.
PMID: 25168226
MicroRNAs are small noncoding RNAs acting as physiological regulators of gene expression at the post-transcriptional level. In cancer, the expression of microRNAs is dysregulated compared to healthy tissue, suggesting a...
10.
Vijaya Kumar A, Salem Gassar E, Spillmann D, Stock C, Sen Y, Zhang T, et al.
Int J Cancer
. 2014 Apr;
135(11):2579-92.
PMID: 24752740
Heparan sulfate 3-O-sulfotransferase 2 (HS3ST2), an enzyme mediating 3-O-sulfation of heparan sulfate (HS), is silenced by hypermethylation in breast cancer. As HS has an important co-receptor function for numerous signal...